 |
 |
 |
 |
Invited Speakers |  |
| Program | ||
| Registration | ||
| Posters & abstract submission | ||
| General information | ||
| Sponsors | ||
| Organizing Committee | ||
| Conference Secretariat | ||
| Back to Homepage | ||
 |
 |
 |
Program
| TUESDAY, September 2, 2008 | |
| 14:00 - 14:15 | Opening ceremony |
| Daniel Zajfman, President of the Weizmann Institute of Science |
|
| Yossi Yarden, Symposium Chairman | |
| 14:00 - 17:30 | Session on Systems Biology of Biological Networks Chairman: Yinon Ben-Neriah |
| 14:15 - 15:00 | PLENARY LECTURE: Boris Kholodenko Spatio-Temporal coding of signal specificity |
| 15:00 - 15:30 | David Gilbert Biochemical models-what can we do with them? |
| 15:30 - 16:00 | Coffee Break |
| 16:00 - 16:30 | Eytan Domany Chromosomal instabilities and cancer |
| 16:30 - 16:45 | Selected Poster: Masha Niv Computational tools for peptidomimetic inhibitors of protein-protein interactions |
| 16:45 - 17:30 | PLENARY LECTURE: Ravi Iyengar Spatial regulation of signaling network topology |
| WEDNESDAY, September 3, 2008 | |
| 09:00 - 12:35 | Session on Biochemical Analysis of Complex Signaling Pathways Chairman: Gideon Rechavi |
| 09:00 - 09:45 | PLENARY LECTURE: Michael Yaffe A systems biology approach to apoptotic control and DNA damage signaling |
| 09:45 - 10:15 | Kun-Liang Guan TSC-mTOR pathway in cell growth |
| 10:15 - 10:45 | Piero Crespo Dimers and scaffolds as spatial regulators of ERK signals |
| 10:45 - 11:05 | Coffee Break |
| 11:05 - 11:35 | Rony Seger Nuclear shuttling of ERKs and MEKs: Novel mechanism on the way to oncogenic transformation |
| 11:35 - 11:50 | Selected Poster: David Engelberg Production of constitutively active p38s and ERKs, and revealing their mechanism of action |
| 11:50 - 12:35 | PLENARY LECTURE: Richard Marais RAS and RAF signalling in melanoma |
| 12:35 - 14:30 | Lunch Break & Poster Presentation |
| 14:30 - 17:45 | Session on Clinical Applications of Signaling Networks Chairman: Ron Pinter |
| 14:30 - 15:15 | PLENARY LECTURE: Gordon Mills A systems approach to drug development and implementation |
| 15:15 - 15:45 | Marco Pierotti Targeted therapy: Lesson from GIST and chordoma tumors |
| 15:45 - 16:05 | Coffee Break |
| 16:05 - 16:35 | Josep Tabernero Molecular biology factors determinant of antitumor activity with targeted therapies in colorectal cancer |
| 16:35 - 16:50 | Selected Poster: Noam Shomron MicroRNAs as oncofetal gene regulators |
| 16:50 - 17:05 | Varda Rotter Identification of specific gene signatures along the process of cell transformation in vitro: relevance to p53 |
| 17:05 - 17:50 | PLENARY LECTURE: Stephen Friend The emerging translational oncology toolkit |
| 17:50 – 18:00 | CONCLUDING REMARKS |